Icam-1 and E-Selectin Expression in Lesional Biopsies of Psoriasis Patients Responding to Systemic FK 506 Therapy

References

• Valdimarsson H, Baker BS, Jonsdottir I, Fry L. Psoriasis: a disease of abnormal keratinocyte proliferation induced by T-lymphocytes. Immunol Today 1986; 7: 256–259
   PubMedGoogle Scholar
• Barker JNWN, MacDonald DM. Cutaneous lymphocyte trafficking in the inflammatory dermatoses. Br J Dermatol 1992; 126: 211–215
   PubMed Web of Science ®Google Scholar
• Voorhees JJ. Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses. Arch Dermatol 1983; 119: 541–547
   PubMedGoogle Scholar
• Farber EM, Nickoloff BJ, Recht B, Fraki JE. Stress, symmetry and psoriasis: Possible role of neuropeptides. J Am Acad Dermatol 1986; 14: 305–311
   PubMed Web of Science ®Google Scholar
• Nickoloff BJ, Griffiths CEM, Barker JNWN. The role of adhesion molecules, chemotactic factors and cytokines in inflammatory and neoplastic skin disease—1990 update. J Invest Dermatol, 1990(94)151S–157S
   Google Scholar
• Barker JNWN, Mitra RS, Griffiths CEM, Dixit VM, Nickoloff BJ. Keratinocytes as initiators of inflammation. Lancet 1991; 337: 211–214
   PubMed Web of Science ®Google Scholar
• Horrocks C, Duncan JI, Oliver AM, Thomson AW. Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin A. Clin Exp Immunol 1991; 84: 157–162
   PubMed Web of Science ®Google Scholar
• Groves RW, Allen MH, Barker JNWN, Haskard DO, MacDonald DM. Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol 1991; 124: 117–123
   PubMed Web of Science ®Google Scholar
• Griffiths CEM, Voorhees JJ, Nickoloff BJ. Characterization of intercellular adhesion molecule-1 and HLA-DR in normal and inflamed skin: modulation by interferon-gamma and tumor necrosis factor. J Am Acad Dermatol 1989; 20: 617–629
   PubMed Web of Science ®Google Scholar
• Chin YH, Falanga V, Taylor JR, Cai JP, Bax J. Adherence of human helper/memory T cell subsets to psoriatic dermal endothelium. J Invest Dermatol 1990; 94: 413–418
   PubMed Web of Science ®Google Scholar
• Dustin ML, Singer KH, Tuck DT, Springer TA. Adhesion of T-lymphoblasts to epidermal keratinocytes is regulated by γ-IFN and mediated via ICAM-1. J Exp Med 1988; 167: 1323–1340
   PubMed Web of Science ®Google Scholar
• Kino T, Hatanaka H, Hashimoto M. FK 506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physicochemical and biological characteristics. J Antibiot (Tokyo) 1987; 40: 1249–1255
   PubMed Web of Science ®Google Scholar
• Zeevi A, Duquesnoy R, Eiras G, Rabinowich H, Todo S, Makowka L, Starzl TE. Immunosuppressive effect of FK 506 on in vitro lymphocyte alloactivation: synergism with cyclo-sporine A. Transplant Proc 1987; 19: 40–44
   PubMed Web of Science ®Google Scholar
• Tocci MJ, Matkovich DA, Collier KA. The immunosuppressant FK 506 selectively inhibits expression of early T cell activation genes. J Immunol 1989; 143: 718–726
   PubMed Web of Science ®Google Scholar
• Thomson AW. FK 506: Profile of an important new immunosuppressant. Transplant Rev 1990; 4: 1–13
   Google Scholar
• Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK 506. Immunol Today 1992; 13: 136–142
   PubMedGoogle Scholar
• Sigal NH, Dumont FJ. Cyclosporin A, FK 506, and rapamy-cin: Pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol 1992; 10: 519–60
   PubMed Web of Science ®Google Scholar
• Starzl TE, Fung JJ, Venkataramanan R, Todo S, Demetris AJ, Jain A. FK 506 for liver, kidney and pancreas transplantation. Lancet 1989; ii: 1000–1004
   Google Scholar
• Thomson AW, Starzl TE. FK 506 and autoimmune disease: perspective and prospects. Autoimmunity 1992; 12: 303–313
   PubMed Web of Science ®Google Scholar
• Abu-Elmagd K, van Thiel DH, Jegasothy BV. FK 506-a new therapeutic agent for severe, recalcitrant psoriasis. Transplant Proc 1991; 23: 3322–3324
   PubMed Web of Science ®Google Scholar
• Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978; 157: 238–244
   PubMedGoogle Scholar
• Tamura K, Kobayashi M, Hashimoto K. A highly sensitive method to assay FK 506 levels in plasma. Transplant Proc 1987; 19: 23–29
   PubMed Web of Science ®Google Scholar
• Liu J, Farmer JD, Lane WS, Friedman J, Weissman L, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK 506 complexes. Cell 1991; 66: 807–815
   PubMed Web of Science ®Google Scholar
• Flanagan WM, Corthesy B, Bram RJ, Crabtree GR. Nuclear association of a T-cell transcription factor blocked by FK 506 and cyclosporin A. Nature 1991; 352: 803–807
   PubMed Web of Science ®Google Scholar
• Ellis CN, Hamilton TA, Billings JK, Brown MD, Headington JT, Cooper KD. Cyclosporine improves psoriasis in a double blind study. JAMA 1986; 256: 3110–3116
   PubMed Web of Science ®Google Scholar
• Horrocks C, Ormerod AD, Duncan JI, Thomson AW. Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions. Clin exp Immunol 1989; 78: 166–171
   PubMed Web of Science ®Google Scholar
• Baker BS, Griffiths CEM, Lambert S, Powles AV, Leonard JN, Valdimarsson H, Fry L. The effect of cyclosporin A on T-lymphocyte and dendritic cell subpopulations in psoriasis. Br J Dermatol 1987; 116: 503–510
   PubMed Web of Science ®Google Scholar
• Munro JM, Pober JS, Cotran RS. Tumor necrosis factor and interferon-gamma induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of. Papio anubis. Am J Pathol 1989; 135: 121–133
   PubMed Web of Science ®Google Scholar
• Griffiths CEM, Nickoloff BJ. Keratinocyte intercellular adhesion molecule-1 (ICAM-I) expression precedes dermal T lymphocytic infiltration in allergic contact dermatitis (Rhus Dermatitis). Am J Pathol 1989; 135: 1045–1053
   PubMed Web of Science ®Google Scholar
• Kato N, Halprin KM, Taylor JR. CsA does not inhibit epidermal cell growth at therapeutic levels. J Invest Dermatol 1987; 88: 52–54
   PubMed Web of Science ®Google Scholar
• Starzl TE, Porter KA, Mazzaferro V, Todo S, Fung J, Francavilla A. Hepatotrophic effects of FK 506 in dogs. Transplantation 1991; 51: 67–70
   PubMed Web of Science ®Google Scholar
• Bevilacqua MP, Stengelin S, Gimbrone MA, Jr, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160–1165
   PubMed Web of Science ®Google Scholar
• Picker LJ, Kishimoto TK, Smith CW, Warnock RA, Butcher EC. ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 1991; 349: 796–799
   PubMed Web of Science ®Google Scholar
• Haug CE, Colvin RB, Delmonico FL, Auchincloss H, Tolkoff-Rubin N, Preffer FI. A phase 1 trial of immuno-suppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 1993; 55: 766–773
   PubMed Web of Science ®Google Scholar
• Fung JJ, Alessiani M, Abu-Elmagd K, Todo S, Shapiro R, Tzakis A. Adverse effects associated with the use of FK 506. Transplant Proc 1991; 23: 3105–3108
   PubMed Web of Science ®Google Scholar